ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 7 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,392,450 | +175.9% | 109,500 | +195.9% | 0.01% | +200.0% |
| Q2 2023 | $7,027,780 | -34.9% | 37,000 | -31.4% | 0.00% | -50.0% |
| Q1 2023 | $10,797,248 | -31.1% | 53,900 | -18.2% | 0.00% | -42.9% |
| Q4 2022 | $15,661,135 | -22.0% | 65,900 | -34.3% | 0.01% | -22.2% |
| Q3 2022 | $20,076,000 | -49.3% | 100,300 | -63.1% | 0.01% | -47.1% |
| Q2 2022 | $39,613,000 | – | 271,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 84,300 | $15,917,000 | 0.02% |
| SIMPLEX TRADING, LLC | 33,600 | $5,703,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 36,000 | $6,797,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |